Jennifer Foster , Leslie Guerrero , Benjamin F. Chong
{"title":"营养不良性皮肤钙质沉着症的疗效评价:系统综述","authors":"Jennifer Foster , Leslie Guerrero , Benjamin F. Chong","doi":"10.1016/j.xjidi.2025.100368","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Calcinosis cutis is a skin condition characterized by calcium salt deposition in the skin and subcutaneous tissues, significantly affecting patients' QOL. Owing to its rarity and lack of standardized outcome measures, there are no approved medications.</div></div><div><h3>Objective</h3><div>This systematic review aims to summarize clinically relevant outcome measures used to assess dystrophic calcinosis cutis.</div></div><div><h3>Methods</h3><div>A systematic literature search was conducted in Medline, Embase, and Web of Science. Studies were included if they reported clinical outcomes assessing dystrophic calcinosis cutis. Data extraction and risk of bias assessment were performed independently by 2 researchers using standardized tools.</div></div><div><h3>Results</h3><div>Twenty-six studies met inclusion criteria, with the majority being retrospective observational studies. Commonly used outcome measures included clinician-reported measures (73.1%), imaging (50.0%), and patient-reported outcomes (42.3%). Radiographs were the most frequently used imaging modality. No consistent outcome measures were identified across studies.</div></div><div><h3>Conclusion</h3><div>There is a lack of standardized outcome measures for dystrophic calcinosis cutis, impeding treatment development. Incorporating patient-reported outcomes is crucial for assessing treatment impact on QOL in this refractory condition. To promote new therapeutics for calcinosis cutis, objective outcome measures, such as imaging, need to be developed and prospectively validated in patients with calcinosis cutis.</div></div>","PeriodicalId":73548,"journal":{"name":"JID innovations : skin science from molecules to population health","volume":"5 4","pages":"Article 100368"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Outcome Measures in Dystrophic Calcinosis Cutis: A Systematic Review\",\"authors\":\"Jennifer Foster , Leslie Guerrero , Benjamin F. Chong\",\"doi\":\"10.1016/j.xjidi.2025.100368\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Calcinosis cutis is a skin condition characterized by calcium salt deposition in the skin and subcutaneous tissues, significantly affecting patients' QOL. Owing to its rarity and lack of standardized outcome measures, there are no approved medications.</div></div><div><h3>Objective</h3><div>This systematic review aims to summarize clinically relevant outcome measures used to assess dystrophic calcinosis cutis.</div></div><div><h3>Methods</h3><div>A systematic literature search was conducted in Medline, Embase, and Web of Science. Studies were included if they reported clinical outcomes assessing dystrophic calcinosis cutis. Data extraction and risk of bias assessment were performed independently by 2 researchers using standardized tools.</div></div><div><h3>Results</h3><div>Twenty-six studies met inclusion criteria, with the majority being retrospective observational studies. Commonly used outcome measures included clinician-reported measures (73.1%), imaging (50.0%), and patient-reported outcomes (42.3%). Radiographs were the most frequently used imaging modality. No consistent outcome measures were identified across studies.</div></div><div><h3>Conclusion</h3><div>There is a lack of standardized outcome measures for dystrophic calcinosis cutis, impeding treatment development. Incorporating patient-reported outcomes is crucial for assessing treatment impact on QOL in this refractory condition. To promote new therapeutics for calcinosis cutis, objective outcome measures, such as imaging, need to be developed and prospectively validated in patients with calcinosis cutis.</div></div>\",\"PeriodicalId\":73548,\"journal\":{\"name\":\"JID innovations : skin science from molecules to population health\",\"volume\":\"5 4\",\"pages\":\"Article 100368\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JID innovations : skin science from molecules to population health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667026725000244\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JID innovations : skin science from molecules to population health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667026725000244","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
皮肤钙质沉着症是一种以钙盐沉积在皮肤和皮下组织为特征的皮肤疾病,严重影响患者的生活质量。由于其罕见和缺乏标准化的结果测量,没有批准的药物。目的本系统综述旨在总结用于评估皮肤营养不良性钙质沉着症的临床相关结果指标。方法在Medline、Embase、Web of Science中进行系统的文献检索。如果研究报告了评估皮肤营养不良性钙质沉着症的临床结果,则纳入研究。数据提取和偏倚风险评估由2名研究者使用标准化工具独立完成。结果26项研究符合纳入标准,多数为回顾性观察性研究。常用的结果测量包括临床报告的测量(73.1%)、影像学检查(50.0%)和患者报告的结果(42.3%)。x线片是最常用的成像方式。在所有研究中没有确定一致的结果测量。结论皮肤营养不良性钙质沉着症缺乏标准化的预后指标,阻碍了治疗的发展。纳入患者报告的结果对于评估治疗对这种难治性疾病生活质量的影响至关重要。为了促进皮肤钙质沉着症的新治疗方法,需要开发客观的结果测量,如影像学,并在皮肤钙质沉着症患者中进行前瞻性验证。
Outcome Measures in Dystrophic Calcinosis Cutis: A Systematic Review
Background
Calcinosis cutis is a skin condition characterized by calcium salt deposition in the skin and subcutaneous tissues, significantly affecting patients' QOL. Owing to its rarity and lack of standardized outcome measures, there are no approved medications.
Objective
This systematic review aims to summarize clinically relevant outcome measures used to assess dystrophic calcinosis cutis.
Methods
A systematic literature search was conducted in Medline, Embase, and Web of Science. Studies were included if they reported clinical outcomes assessing dystrophic calcinosis cutis. Data extraction and risk of bias assessment were performed independently by 2 researchers using standardized tools.
Results
Twenty-six studies met inclusion criteria, with the majority being retrospective observational studies. Commonly used outcome measures included clinician-reported measures (73.1%), imaging (50.0%), and patient-reported outcomes (42.3%). Radiographs were the most frequently used imaging modality. No consistent outcome measures were identified across studies.
Conclusion
There is a lack of standardized outcome measures for dystrophic calcinosis cutis, impeding treatment development. Incorporating patient-reported outcomes is crucial for assessing treatment impact on QOL in this refractory condition. To promote new therapeutics for calcinosis cutis, objective outcome measures, such as imaging, need to be developed and prospectively validated in patients with calcinosis cutis.